What we're reading, January 23, 2017: it is currently unclear what the impact President Donald Trump's executive order will have on the Affordable Care Act; New York requires that insurers cover birth control and abortions; and hospitals reexamine guidelines for opioid prescribing.
On day 1 in the White House, President Donald J. Trump signed an executive order impacting how the Affordable Care Act (ACA) is implemented. However, the order’s effect on the health law is unclear, and experts spent the weekend trying to decode it, reported The Wall Street Journal. The order may indicate that the new administration will stop enforcing the individual mandate, but no official statement has been made yet. Nevertheless, the order cannot repeal the ACA or do away with funding for coverage—only Congress has the power to do that.
New York State is taking measures to ensure women have access to contraception even if the ACA is repealed. According to Bloomberg, Governor Andrew Cuomo has ordered health insurers to cover birth control and medically necessary abortions in the event that a repeal is signed into law. Since insurance is regulated at both the federal and state levels, states may preserve parts of the ACA and continue to enforce provisions even if the federal government repeals the health law.
In the wake of the opioid epidemic, hospitals are reexamining guidelines for prescribing opioids in the emergency department (ED). STAT reported that hospitals are retraining ED doctors to minimize opioid prescriptions. At UK Healthcare, opioids are now only prescribed as a last resort, and St. Joseph’s Regional Medical Center in New Jersey is replacing opiods with less-addictive drugs and has a harpist playing music in the hallways of the ED. While these changes may prevent new addicts, they do not always address people who are already chronic opioid users.
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate
April 17th 2024A new study is among the largest real-world analyses to date to assess trends over time and predictive factors for older patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic cell transplantation (allo-HCT).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from the Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen